(Q37171590)

18 August 2017

1 reference

title

Human papillomavirus vaccines and the potential for cross-protection between related HPV types (English)

1 reference

18 August 2017

1 reference

Kevin A Ault

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

18 August 2017

1 reference

18 August 2017

volume

107

1 reference

18 August 2017

issue

2 Suppl 1

1 reference

18 August 2017

page(s)

S31-3

1 reference

The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

Classification of papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.059

10.1016/J.YGYNO.2007.08.059

7 January 2021

Identifiers

DOI

1 reference

release_vvy3fxc42banza4j2fqeioloci

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vvy3fxc42banza4j2fqeioloci

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference